WallStreetZen

NASDAQ: AMED
Amedisys Inc Stock Forecast, Predictions & Price Target

Analyst price target for AMED

Based on 10 analysts offering 12 month price targets for Amedisys Inc.
Min Forecast
$181.00+32.41%
Avg Forecast
$220.20+61.08%
Max Forecast
$340.00+148.72%

Should I buy or sell AMED stock?

Based on 10 analysts offering ratings for Amedisys Inc.
Buy
Strong Buy
3 analysts 30%
Buy
4 analysts 40%
Hold
3 analysts 30%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

AMED stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Raymond James
Top 16%
85
BuyMaintains$225.00+64.59%2021-11-08
Credit Suisse
Bottom 7%
7
BuyMaintains$205.00+49.96%2021-11-04
Stephens & Co.
Top 17%
84
HoldMaintains$185.00+35.33%2021-11-04
RBC Capital
Bottom 4%
4
BuyMaintains$221.00+61.67%2021-11-04
SVB Leerink
Top 36%
65
HoldMaintains$181.00+32.41%2021-11-04
Oppenheimer
Top 45%
56
BuyMaintains$225.00+64.59%2021-11-03
Truist Securities
Top 15%
86
Strong BuyMaintains$190.00+38.99%2021-10-13
Anonymous
UBS
Strong SellInitiates Coverage On$150.00+9.73%2021-09-24
Cowen & Co.
Bottom 4%
4
HoldInitiates Coverage On$195.00+42.65%2021-09-10
Benchmark
Top 6%
95
Strong BuyMaintains$235.00+71.91%2021-08-10

1 of 2

Forecast return on equity

Is AMED forecast to generate an efficient return?
Company
N/A
Industry
4.52%
Market
37.5%

Forecast return on assets

Is AMED forecast to generate an efficient return on assets?
Company
N/A
Industry
0.08%

AMED earnings per share forecast

What is AMED's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$6.08-9.79%
Avg 2 year Forecast
$6.50-3.56%
Avg 3 year Forecast
$7.86+16.62%
AMED's earnings are forecast to grow at a rate of 3.81% per year, which is not exceptional
Forecast

AMED revenue forecast

What is AMED's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$2.2B-0.04%
Avg 2 year Forecast
$2.4B+7.16%
Avg 3 year Forecast
$2.6B+17.89%
AMED's revenue is forecast to grow at a rate of 5.34% per year, which is not exceptional
Forecast

AMED earnings growth forecast

How is AMED forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
3.81%
Industry
1.34%
Market
14.37%
AMED's earnings are forecast to grow faster (3.81% per year) than the US Medical Care Facilities industry average (1.34%)
Forecast
AMED's earnings are forecast to grow slower (3.81% per year) than the US market average (14.37%)
Forecast
AMED's earnings are forecast to grow faster (3.81% per year) than the risk-free savings rate (1.4%)
Forecast

AMED revenue growth forecast

How is AMED forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
5.34%
Industry
6.87%
Market
10.08%
AMED's revenues are forecast to grow slower (5.34% per year) than the US Medical Care Facilities industry average (6.87%)
Forecast
AMED's revenues are forecast to grow slower (5.34% per year) than the US market average (10.08%)
Forecast

Amedisys Stock Forecast FAQ

Is Amedisys Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: AMED) stock is to Buy AMED stock.

Out of 10 analysts, 3 (30%) are recommending AMED as a Strong Buy, 4 (40%) are recommending AMED as a Buy, 3 (30%) are recommending AMED as a Hold, 0 (0%) are recommending AMED as a Sell, and 0 (0%) are recommending AMED as a Strong Sell.

What is AMED's earnings growth forecast for 2021-2023?

(NASDAQ: AMED) Amedisys's forecast annual earnings growth rate of 3.81% is forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 1.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Amedisys's earnings in 2021 is $220,176,000.On average, 7 Wall Street analysts forecast AMED's earnings for 2021 to be $198,222,744, with the lowest AMED earnings forecast at $196,918,647, and the highest AMED earnings forecast at $199,526,841. On average, 8 Wall Street analysts forecast AMED's earnings for 2022 to be $211,915,763, with the lowest AMED earnings forecast at $195,940,574, and the highest AMED earnings forecast at $221,696,490.

In 2023, AMED is forecast to generate $256,255,061 in earnings, with the lowest earnings forecast at $243,866,139 and the highest earnings forecast at $263,101,570.

What is AMED's revenue growth forecast for 2021-2023?

(NASDAQ: AMED) Amedisys's forecast annual revenue growth rate of 5.34% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Amedisys's revenue in 2021 is $2,205,500,000.On average, 8 Wall Street analysts forecast AMED's revenue for 2021 to be $71,878,664,205, with the lowest AMED revenue forecast at $71,709,033,788, and the highest AMED revenue forecast at $72,224,152,103. On average, 8 Wall Street analysts forecast AMED's revenue for 2022 to be $77,055,212,041, with the lowest AMED revenue forecast at $74,936,673,863, and the highest AMED revenue forecast at $78,500,118,915.

In 2023, AMED is forecast to generate $84,771,521,388 in revenue, with the lowest revenue forecast at $83,299,195,875 and the highest revenue forecast at $85,486,818,593.

What is AMED's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: AMED) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of 0.08%.

What is AMED's Price Target?

According to 10 Wall Street analysts that have issued a 1 year AMED price target, the average AMED price target is $220.20, with the highest AMED stock price forecast at $340.00 and the lowest AMED stock price forecast at $181.00.

On average, Wall Street analysts predict that Amedisys's share price could stay at $220.20 by Nov 8, 2022. The average Amedisys stock price prediction forecasts a potential downside of N/A from the current AMED share price of $136.70.

What is AMED's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: AMED) Amedisys's current Earnings Per Share (EPS) is $6.74. On average, analysts forecast that AMED's EPS will be $6.08 for 2021, with the lowest EPS forecast at $6.04, and the highest EPS forecast at $6.12. On average, analysts forecast that AMED's EPS will be $6.50 for 2022, with the lowest EPS forecast at $6.01, and the highest EPS forecast at $6.80. In 2023, AMED's EPS is forecast to hit $7.86 (min: $7.48, max: $8.07).

What is AMED's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: AMED) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.